# Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus

> **NCT06475586** · PHASE4 · COMPLETED · sponsor: **University of Banja Luka** · enrollment: 30 (actual)

## Conditions studied

- Psoriasis Vulgaris
- Diabetes Type 2

## Interventions

- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT06475586
- **Lead sponsor:** University of Banja Luka
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-03
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-06-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06475586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06475586, "Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06475586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*